Yatharth Hospital and Trauma Care Services Ltd
Tue 25/11/2025,16:14:7 | NSE : YATHARTH
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 795.00
Previous Close
₹ 783.40
Volume
340225
Mkt Cap ( Rs. Cr)
₹7439.52
High
₹ 795.00
Low
₹ 756.30
52 Week High
₹ 843.70
52 Week Low
₹ 345.60
Book Value Per Share
₹ 166.62
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Yatharth Hospital and Trauma Care Services Ltd
Your Vote -
Buy
71.43%
Hold
7.94%
Sell
20.63%
71.43%
63 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
772.10
280
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
280
Option Chain
Analyzes market sentiment, predicts Yatharth Hospital and Trauma Care Services Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Copy of Newspaper Publication
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Yatharth Hospital - Monitoring Agency Report
-
Yatharth Hospital - Monitoring Agency Report
-
Yatharth Hospital - Investor Presentation
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Yatharth Hospital - Press Release
-
Yatharth Hospital - Outcome of Board Meeting
-
Yatharth Hospital - General Updates
-
Yatharth Hospital Q2 net profit up 1.18% at Rs 20.64 cr
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Yatharth Hospital - Financial Results Of The Company For Second Quarter And Half Year Ended September 30, 2025.
-
Yatharth Hospital - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company
-
Yatharth Hospital - Announcement Under Reg. 30 (LODR)- Update On Income Tax Matter
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Yatharth Hospital - Board Meeting Intimation for Unaudited Financial Results For The Second Quarter FY26
-
Yatharth Hospital - Credit Rating
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Credit Rating
-
Yatharth Hospital - Change in Management
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Change in Management
-
Yatharth Hospital - Commencement of commercial production/operations
-
Yatharth Hospital - Intimation Of Commencement Of Operations Of M/S. MGS Infotech Research And Solutions Private Limited (A S
-
Yatharth Hospital has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Yatharth Hospital - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Yatharth Hospital - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Yatharth Hospital - Appointment Of The Statutory Auditor And Secretarial Auditor Of The Company
-
Yatharth Hospital - Change in Auditors
-
Yatharth Hospital - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Yatharth Hospital - Voting Results Of The 18Th Annual General Meeting
-
Yatharth Hospital - General Updates
-
Yatharth Hospital - Shareholders meeting
-
Yatharth Hospital - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Yatharth Hospital - Shareholders meeting
-
Yatharth Hospital - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Yatharth Hospital - Trading Window
-
Yatharth Hospital - Press Release
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Yatharth Hospital - General Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Acquisition
-
Yatharth Hospital - Copy of Newspaper Publication
-
Yatharth Hospital - General Updates
-
Yatharth Hospital - Business Responsibility and Sustainability Reporting (BRSR)
-
Yatharth Hospital - Reg. 34 (1) Annual Report.
-
Yatharth Hospital - Shareholders meeting
-
Yatharth Hospital - Notice Of 18Th Annual General Meeting Of The Company
-
Yatharth Hospital - General Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Yatharth Hospital - Analysts/Institutional Investor Meet/Con. Call Updates
-
Yatharth Hospital - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Yatharth Hospital
-
Yatharth Hospital
Key fundamentals
Evaluate the intrinsic value of Yatharth Hospital and Trauma Care Services Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1525.145 | 840.522 | 289.756 | 220.908 | 161.7533 |
| Liabilities | 1525.145 | 840.522 | 289.756 | 220.908 | 161.7533 |
| Equity | 96.354 | 85.85 | 65.517 | 65.517 | 16.3792 |
| Gross Profit | 127.018 | 117.311 | 105.308 | 84.175 | 41.7071 |
| Net Profit | 87.692 | 83.994 | 64.174 | 42.087 | 15.5049 |
| Cash From Operating Activities | 88.683 | 15.963 | 25.582 | 26.267 | 23.7645 |
| NPM(%) | 19.3 | 20 | 17.27 | 14.09 | 9.41 |
| Revenue | 454.241 | 419.791 | 371.514 | 298.59 | 164.7276 |
| Expenses | 327.223 | 302.48 | 266.206 | 214.415 | 123.0205 |
| ROE(%) | 5.46 | 5.23 | 3.99 | 2.62 | 0.96 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Yatharth Hospital and Trauma Care Services Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 784.10 | 0.47 | 0.00 | 440.94 | 301.39 | 0.64 |
| Lotus Eye Hospital and Institute Ltd | 107.49 | 2.37 | 335.91 | 1606.72 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 8.90 | -2.31 | 0.00 | 10079.50 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 918.75 | 3.23 | 0.00 | 1515.18 | -604.77 | 0.00 |
Company Info
Our Company was incorporated as `Yatharth Hospital & Trauma Care Services Private Limited' in Delhi as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated February 28, 2008, issued by the RoC. Pursuant to a special resolution passed by our Shareholders on November 3, 2021, our Company was converted into a public limited company and consequently, the name of our Company was changed to `Yatharth Hospital & Trauma Care Services Limited' and a fresh certificate of incorporation dated November 18, 2021 was issued by the RoC.Major events and milestones:2010 - Established our first hospital (i.e., Greater Noida Hospital)2013- Established our second hospital (i.e., Noida Hospital)2019-Commenced operations at our third hospital (i.e., Noida Extension Hospital) which was acquired in 2016pursuant to acquisition of our Subsidiary, AKS2022-Acquired fourth hospital (i.e., Jhansi-Orchha Hospital) pursuant to acquisition of our Subsidiary, Ramraja.2023-Yatharth Hospital Got Prestigious Recognition Of Best Brand 2023. 2024 -Acquisition of 60% Equity Share in MGS Infotech Research and Solutions Private Limited.
Our Company was incorporated as `Yatharth Hospital & Trauma Care Services Private Limited' in Delhi as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated February 28, 2008, issued by the RoC. Pursuant to a special resolution passed by our Shareholders on November 3, 2021, our Company was converted into a public limited company and consequently, the name of our Company was changed to `Yatharth Hospital & Trauma Care Services Limited' and a fresh certificate of incorporation dated November 18, 2021 was issued by the RoC.Major events and milestones:2010 - Established our first hospital (i.e., Greater Noida Hospital)2013- Established our second hospital (i.e., Noida Hospital)2019-Commenced operations at our third hospital (i.e., Noida Extension Hospital) which was acquired in 2016pursuant to acquisition of our Subsidiary, AKS2022-Acquired fourth hospital (i.e., Jhansi-Orchha Hospital) pursuant to acquisition of our Subsidiary, Ramraja.2023-Yatharth Hospital Got Prestigious Recognition Of Best Brand 2023. 2024 -Acquisition of 60% Equity Share in MGS Infotech Research and Solutions Private Limited.
Read More
Parent Organisation
Yatharth Hospital & Trauma Care Services Ltd.
Founded
28/02/2008
Managing Director
Dr.Kapil Kumar
NSE Symbol
YATHARTHEQ
FAQ
The current price of Yatharth Hospital and Trauma Care Services Ltd is ₹ 772.10.
The 52-week high for Yatharth Hospital and Trauma Care Services Ltd is ₹ 795.00 and the 52-week low is ₹ 756.30.
The market capitalization of Yatharth Hospital and Trauma Care Services Ltd is currently ₹ 7439.52. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Yatharth Hospital and Trauma Care Services Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Yatharth Hospital and Trauma Care Services Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Yatharth Hospital and Trauma Care Services Ltd shares.
The CEO of Yatharth Hospital and Trauma Care Services Ltd is Dr.Kapil Kumar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.